CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $73,265
- in 1 filing
Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-12 | Buell Jennifer Chief Executive Officer | Sale | −6,938 | $10.56 | $73K | 74,195 |
| 2026-06-04 | Ryan Barbara Director | Sale | −500 | $12.68 | $6K | 22,969 |
| 2026-06-04 | Ryan Barbara Director | Sale | −1,000 | $12.80 | $13K | 21,969 |
| 2026-03-10 | Ryan Barbara Director | Sale | −300 | $15.28 | $5K | 21,406 |
| 2026-03-10 | Ryan Barbara Director | Sale | −500 | $15.57 | $8K | 20,906 |
| 2026-03-10 | Ryan Barbara Director | Sale | −500 | $15.30 | $8K | 20,406 |
| 2026-03-09 | Ryan Barbara Director | Sale | −200 | $10.17 | $2K | 21,706 |
Page 1 of 1 · 7 trades